187 related articles for article (PubMed ID: 17111779)
1. The faster the better?
Carulli N
Intern Emerg Med; 2006; 1(2):91-3. PubMed ID: 17111779
[No Abstract] [Full Text] [Related]
2. [Therapy of chronic Hepatitis C in 2008].
Niederau C; Kaden T
MMW Fortschr Med; 2008 Mar; 150(13):31-4. PubMed ID: 18522354
[No Abstract] [Full Text] [Related]
3. [Treatment of patients with chronic hepatitis C who relapsed or did not respond to a previous treatment].
Zoulim F
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B225-30. PubMed ID: 12180293
[No Abstract] [Full Text] [Related]
4. [Treatment of patients with chronic hepatitis C who never had been treated].
Hézode C
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B38-49. PubMed ID: 12180307
[No Abstract] [Full Text] [Related]
5. [Effectiveness of long-acting interferon (peginterferon)].
Kondo Y; Tateishi R; Yoshida H; Omata M
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):515-8. PubMed ID: 15359853
[No Abstract] [Full Text] [Related]
6. [Hepatitis C: therapeutic perspectives].
Trépo C
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B297-302. PubMed ID: 12180304
[No Abstract] [Full Text] [Related]
7. [Antiviral treatments during cirrhosis].
Bronowicki JP
Gastroenterol Clin Biol; 2006; 30(6-7):899-902. PubMed ID: 16885876
[No Abstract] [Full Text] [Related]
8. The evolving treatment of chronic hepatitis C: where we stand a decade out.
Saadeh S; Davis GL
Cleve Clin J Med; 2004 May; 71 Suppl 3():S3-7. PubMed ID: 15468610
[TBL] [Abstract][Full Text] [Related]
9. [Combination therapy of interferon plus ribavirin for chronic hepatitis C].
Asahina Y; Izumi N
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):467-73. PubMed ID: 15359843
[No Abstract] [Full Text] [Related]
10. Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study.
Benetti G; Borzio M; Ramella G; Bellati G; Fargion S; Colombo A; Croce G; Iamoletti C; Balzola F; Rizzetto M;
Intern Emerg Med; 2006; 1(2):113-8. PubMed ID: 17111783
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effects of interferon on chronic hepatitis C from the aspect of dosage and method of administration].
Fukuda A
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):493-6. PubMed ID: 15359848
[No Abstract] [Full Text] [Related]
12. [Hepatitis C].
Moradpour D; Blum HE
Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
[TBL] [Abstract][Full Text] [Related]
13. Response-guided therapy: optimizing treatment now and in the future.
Marcellin P; Rizzetto M
Antivir Ther; 2008; 13 Suppl 1():1-2. PubMed ID: 18432156
[No Abstract] [Full Text] [Related]
14. [Hepatitis C and liver transplantation].
Durand F
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B82-90. PubMed ID: 12180312
[No Abstract] [Full Text] [Related]
15. [Chronic hepatitis C: what to do if the first treatment failed?].
Asselah T
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B50-9. PubMed ID: 12180309
[No Abstract] [Full Text] [Related]
16. Efficacy of pegylated interferon and ribavirin combination therapy for patients with hepatitis C virus infection after curative resection or ablation for hepatocellular carcinoma--A retrospective multicenter study.
Harada N; Hiramatsu N; Oze T; Tatsumi T; Hayashi N; Takehara T
J Med Virol; 2015 Jul; 87(7):1199-206. PubMed ID: 25772024
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic hepatitis C in southern Taiwan.
Chuang WL; Yu ML; Dai CY; Chang WY
Intervirology; 2006; 49(1-2):99-106. PubMed ID: 16166797
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of virological response on sustained virological response in hepatitis C patients].
Zhou YQ; Wang XH; Fan Y; Zhu Y; Tan WT; Mao Q
Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):944-6. PubMed ID: 20038340
[No Abstract] [Full Text] [Related]
19. Non-responders to previous treatment for hepatitis C.
Gross JB
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):47-54. PubMed ID: 15756145
[TBL] [Abstract][Full Text] [Related]
20. Impaired response to interferon-alpha2b plus ribavirin in cirrhotic patients with genotype 3a hepatitis C virus infection.
Aghemo A; Rumi MG; Soffredini R; D'Ambrosio R; Ronchi G; Del Ninno E; Gallus S; Colombo M
Antivir Ther; 2006; 11(6):797-802. PubMed ID: 17310824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
